Nanotechnology is an interdisciplinary domain of science, technology and engineering that
deals with nano-sized materials/particles. Usually, the size of nanoparticles lies between 1 …

Aggregation of proteins is involved in many disorders. Besides amyloid fibrils, which mostly
form in the brain, other kind of protein aggregates can lead, for example, to clots in the blood …

The oligomerization of Aβ16–22 peptide, which is the hydrophobic core region of full-length
Aβ1–42, causes Alzheimer's disease (AD). This progressive neurodegenerative disease …

Amyloid-β [Aβ (1–40)] aggregation into a fibrillar network is one of the major hallmarks of
Alzheimer's disease (AD). Recently, a few studies reported that polyphosphate (polyP), an …

Protein fibrillation is a phenomenon associated with misfolding and the production of highly
ordered nanofibrils, which may cause serious degenerative diseases such as Parkinson's …

Fibrillogenesis of amyloid β-protein (Aβ) is a pathological hallmark of Alzheimer's disease,
so inhibition of Aβ aggregation is considered as an important strategy for the precaution and …

Investigation of targeting inhibitors of Aβ aggregation, heme-Aβ peroxidase-like activity and
efficient detectors of Aβ aggregation, are of therapeutic value and diagnostics significance …

Peptides and proteins are exposed to a variety of interfaces in a physiological environment,
such as cell membranes, protein nanoparticles (NPs), or viruses. These interfaces have a …

Pro-inflammatory and amyloidogenic S100A9 protein is central to the amyloid-
neuroinflammatory cascade in neurodegenerative diseases. Polyoxometalates (POMs) …

Alzheimer's Disease is a rapidly progressing irreversible neurodegenerative disorder
characterized by neuronal cell deterioration that endangers human health. With its proper …